Finance

Lists
HEAL:IDX
Medikaloka Hermina Tbk PT
IDR 600,00
0,00%
(0,00) 1D
9 Okt., 16:11:49 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for HEAL...
Open
IDR 600
High
IDR 610
Low
IDR 590
Mkt. cap
9,22 bn
Avg. vol.
19,62 m
Volume
10,79 m
Dividend
2,25%
Quarterly dividend
IDR 3
Ex-dividend date
05 Mei 2026
P/E ratio
22,63
52-wk high
IDR 1 610
52-wk low
IDR 575
EPS
IDR 27
Shares outstanding
15,37 mjd
No. of employees
19 k
Open
IDR 600
High
IDR 610
Low
IDR 590
Mkt. cap
9,22 bn
Avg. vol.
19,62 m
Volume
10,79 m
Dividend
2,25%
Quarterly dividend
IDR 3
Ex-dividend date
05 Mei 2026
P/E ratio
22,63
52-wk high
IDR 1 610
52-wk low
IDR 575
EPS
IDR 27
Shares outstanding
15,37 mjd
No. of employees
19 k
News stories
From web sources and news partners
Profile
PT Medikaloka Hermina Tbk is a health service company headquartered in Jakarta, Indonesia. As of December 2024, the hospital network had grown to 52 hospitals operating in 63 cities across 17 provinces in Indonesia. Wikipedia
About Medikaloka Hermina Tbk PT
CEO-
Employees19,2 k
Founded1985
Headquarters-
SectorHealth care provider
Last report
30 Jul. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (IDR)
1,83 bn / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,90 bn
1,85 bn
1,78 bn
1,83 bn
Cost of goods sold
1,29 bn
1,24 bn
1,21 bn
1,24 bn
Cost of revenue
1,29 bn
1,24 bn
1,21 bn
1,24 bn
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
264,88 mjd
313,31 mjd
286,75 mjd
294,40 mjd
Operating expense
327,65 mjd
385,32 mjd
349,98 mjd
365,06 mjd
Total operating expenses
1,62 bn
1,63 bn
1,56 bn
1,61 bn
Operating income
277,92 mjd
216,71 mjd
223,61 mjd
217,42 mjd
Other non operating income
-
-
-
-
EBT including unusual items
224,17 mjd
164,20 mjd
170,90 mjd
160,93 mjd
EBT excluding unusual items
224,90 mjd
164,97 mjd
170,91 mjd
160,69 mjd
Income tax expense
57,41 mjd
66,30 mjd
38,62 mjd
44,18 mjd
Effective tax rate
25,61%
40,38%
22,60%
27,46%
Other operating expenses
-6,38 mjd
-6,72 mjd
-7,80 mjd
-1,18 mjd
Net income
131,17 mjd
73,53 mjd
101,26 mjd
91,92 mjd
Net profit margin
6,91%
3,98%
5,68%
5,03%
Earnings per share
-
-
-
-
Interest and investment income
3,69 mjd
6,08 mjd
3,23 mjd
3,34 mjd
Interest expense
-56,70 mjd
-57,82 mjd
-55,92 mjd
-60,07 mjd
Net interest expenses
-53,02 mjd
-51,74 mjd
-52,70 mjd
-56,73 mjd
Depreciation and amortization charges
69,10 mjd
72,88 mjd
70,90 mjd
71,82 mjd
EBITDA
446,07 mjd
424,70 mjd
450,94 mjd
450,92 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme